Effect of the COVID-19 Pandemic on Delayed Skin Cancer Services - 21/09/21
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Resumen |
The COVID-19 pandemic has presented a unique set of challenges to cancer care centers around the world. Diagnostic and treatment delays associated with lockdown periods may be expected to increase the total number of avoidable skin cancer deaths. During this unprecedented time, dermatologists have been pressed to balance early surgical interventions for skin cancer with the risk of viral transmission. This article summarizes evidenced-based recommendations for the surgical management of cutaneous melanoma, keratinocyte cancer, and Merkel cell carcinoma during the COVID-19 pandemic. Additional long-term studies are required to determine the effect of COVID-19 on skin cancer outcomes.
El texto completo de este artículo está disponible en PDF.Keywords : Surgical delay, Evidence-based guidelines, Time to surgery, Skin cancer, COVID-19, COVID-19 delays, Survival
Esquema
Vol 39 - N° 4
P. 627-637 - octobre 2021 Regresar al número
Artículo precedente
- The Impact of the COVID-19 Pandemic on Global Health Dermatology
- Claire Hannah, Victoria Williams, Lucinda Claire Fuller, Amy Forrestel
- How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World : Perspectives from 11 Countries
- Qisi Sun, Devon E. McMahon, Pearl O. Ugwu-Dike, Qiuning Sun, Keyun Tang, Hanlin Zhang, Poonkiat Suchonwanit, Choon Chiat Oh, Alvin H. Chong, Anneliese Willems, Cristina Galván, Roni P. Dodiuk-Gad, Fabrizio Fantini, Sebastiano Recalcati, Joao Avancini, Denise Miyamoto, Jose A. Sanches, Noufal Raboobee, Francisco Bravo, Esther E. Freeman
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.